Tatva Chintan Pharma Chem Limited has informed the Exchange about Schedule of meet
TATVA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Tatva Chintan Pharma Chem has informed the stock exchanges about a scheduled investor meeting on 12 November 2025. The company will hold a one-on-one physical meeting with SBI Funds Management Private Limited. The disclosure has been made under Regulation 30 of SEBI's Listing Obligations and Disclosure Requirements (LODR) Regulations, 2015. The company has clarified that only publicly available information will be discussed and no unpublished price sensitive information (UPSI) will be shared during the meeting.
This is a routine regulatory disclosure and not expected to cause any immediate price movement. A meeting with SBI Funds Management, a large institutional investor, signals ongoing institutional engagement with the company.